---
title: "Entero Healthcare Solutions Ltd (ENTERO) — Share Price, Financials & Analysis"
symbol: "ENTERO"
company: "Entero Healthcare Solutions Ltd"
canonical: "https://tapetide.com/stocks/ENTERO"
isin: "INE010601016"
nse_symbol: "ENTERO"
bse_code: "544122"
sector: "Retail"
industry: "Pharmacy Retail"
market_cap_cr: 7905.95
generated_at: "2026-09-13T19:12:06.564Z"
---

# Entero Healthcare Solutions Ltd (ENTERO)

Canonical page: https://tapetide.com/stocks/ENTERO

## Company

- **NSE Symbol:** ENTERO
- **BSE Code:** 544122
- **ISIN:** INE010601016
- **Sector:** Retail
- **Industry:** Pharmacy Retail
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2024-02-16
- **CEO:** Mr. Prabhat Agrawal
- **Employees:** 4111
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** enterohealthcare.com

## About

Incorporated in 2018, Entero Healthcare 
Solutions Ltd is in the business of distribution 
and marketing of pharmaceutical and surgical products and allied services[1]

## Latest Price

- **Price:** ₹1815.4
- **Change:** +22.5 (+1.25%)
- **Open:** ₹1792.9
- **Day High:** ₹1840.4
- **Day Low:** ₹1792.9
- **Previous Close:** ₹1792.9
- **Volume:** 98792
- **As Of:** 2026-09-11T09:59:59+00:00

## Key Fundamentals

Observed at 2026-09-11T04:37:12.558336Z.

- **Market Cap:** ₹7905.95 Cr
- **Classification:** Microcap
- **P/E (reported):** 46.6
- **P/E (TTM):** 62.99
- **EPS (TTM):** ₹28.82
- **EPS (reported):** ₹8.99
- **Book Value:** ₹386.51
- **Price to Book:** 4.65
- **Dividend Yield:** 0%
- **ROE:** 8.32%
- **ROCE:** 11.61%
- **Debt to Equity:** 0.4
- **Revenue (yearly):** ₹6610.4 Cr
- **Net Income:** ₹145.8 Cr
- **EBITDA:** ₹285.2 Cr
- **52-Week High:** ₹1920
- **52-Week Low:** ₹944
- **RSI (14):** 68.03

## Tapetide Score

- **Score:** 44 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 25 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 47.64 | 9% |
| growth | 90.69 | 9% |
| momentum | 98.4 | 12% |
| ownership | 44.24 | 24% |
| quality | 25.27 | 22% |
| valuation | 29.01 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has delivered good profit growth of 57.3% CAGR over last 5 years
- Company's working capital requirements have reduced from 49.4 days to 34.8 days

### Weaknesses

- Stock is trading at 4.68 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 6.04% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 225.15% | 362.77% | 372.75% |
| ebitda margin growth | 10.99% | 4.87% | 34.27% | 278.07% |
| net income growth | 15.3% | 35.75% | 130% | 57% |
| revenue growth | 1.55% | 28.72% | 26% | 30% |
| roce | 16.52% | 19.57% | 99.83% | 7.02% |
| roe | 15.33% | 37.07% | 5.6% | -259.08% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 996 | 993 | 1034 | 1097 | 1301 | 1359 | 1339 | 1404 | 1571 | 1707 | 1910 | 1940 |
| Expenses | 968 | 964 | 1005 | 1067 | 1258 | 1309 | 1290 | 1354 | 1509 | 1639 | 1824 | 1844 |
| Operating Profit | 29 | 29 | 29 | 30 | 42 | 50 | 49 | 50 | 62 | 68 | 86 | 97 |
| OPM % | 2.9 | 2.9 | 2.8 | 2.8 | 3.3 | 3.7 | 3.6 | 3.6 | 4 | 4 | 4.5 | 5 |
| Other Income | 2 | 2 | 9 | 13 | 11 | 8 | 7 | 6 | 5 | -4 | 4 | 3 |
| Interest | 18 | 16 | 17 | 10 | 11 | 10 | 10 | 11 | 12 | 14 | 17 | 21 |
| Depreciation | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 15 | 12 |
| Profit before tax | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax % | 23 | 16 | -56 | 25 | 25 | 25 | 16 | 17 | 18 | 16 | 22 | 22 |
| Net Profit | 5 | 7 | 21 | 21 | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| EPS in Rs | 3.19 | 4.22 | 4.82 | 4.62 | 5.43 | 5.85 | 5.9 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1350 | 1773 | 2522 | 3300 | 3922 | 5096 | 6591 | 7128 |
| Expenses | 1326 | 1758 | 2498 | 3236 | 3810 | 4924 | 6325 | 6815 |
| Operating Profit | 23 | 15 | 24 | 64 | 112 | 172 | 266 | 313 |
| OPM % | 1.7 | 0.8 | 1 | 1.9 | 2.9 | 3.4 | 4 | 4.4 |
| Other Income | 5 | 11 | 4 | 6 | 14 | 39 | 11 | 8 |
| Interest | 13 | 20 | 29 | 49 | 66 | 42 | 54 | 64 |
| Depreciation | 12 | 16 | 20 | 24 | 25 | 31 | 43 | 47 |
| Profit before tax | 4 | -11 | -20 | -4 | 36 | 139 | 179 | 210 |
| Tax % | 67 | 42 | 49 | 201 | -12 | 23 | 19 | — |
| Net Profit | 1 | -15 | -29 | -11 | 40 | 107 | 146 | 168 |
| EPS in Rs | 93.81 | -1550.9 | -77.71 | -28.12 | 8.99 | 21.79 | 26.44 | 28.82 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.1 | 0.1 | 4 | 4 | 43 | 44 | 44 |
| Reserves | -16 | -32 | -62 | -73 | 1595 | 1681 | 1645 |
| Borrowings | 603 | 720 | 974 | 1101 | 338 | 385 | 677 |
| Other Liabilities | 162 | 147 | 210 | 275 | 369 | 593 | 1234 |
| Total Liabilities | 749 | 836 | 1125 | 1308 | 2345 | 2703 | 3600 |
| Fixed Assets | 186 | 189 | 262 | 268 | 289 | 559 | 958 |
| CWIP | 2 | 2 | 1 | 0 | 0 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 58 | 130 |
| Other Assets | 560 | 645 | 863 | 1040 | 2056 | 2085 | 2510 |
| Total Assets | 749 | 836 | 1125 | 1308 | 2345 | 2703 | 3600 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -37 | -69 | -35 | -45 | -37 | -77 | 96 |
| Cash from Investing Activity | -203 | -31 | -162 | -49 | -704 | 232 | -302 |
| Cash from Financing Activity | 217 | 89 | 211 | 73 | 863 | -74 | 124 |
| Net Cash Flow | -23 | -11 | 14 | -21 | 122 | 82 | -82 |
| Free Cash Flow | -81 | -78 | -45 | -51 | -41 | -87 | 29 |
| CFO/OP | -134 | -430 | -100 | -51 | -21 | -23 | 56 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 63 | 50 | 54 | 57 | 57 | 59 | 67 |
| Inventory Days | 57 | 54 | 49 | 41 | 43 | 52 | 52 |
| Days Payable | 32 | 22 | 22 | 25 | 24 | 31 | 45 |
| Cash Conversion Cycle | 88 | 82 | 81 | 73 | 77 | 80 | 74 |
| Working Capital Days | 57 | 54 | 41 | 32 | 48 | 65 | 35 |
| ROCE % | — | 1 | 1 | 5 | 7 | 9 | 10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 78.85% | 52.44% | 52.44% | 52.44% | 52.44% | 52.42% | 52.42% | 52.42% | 52.42% | 52.42% | 52.4% |
| FIIs | 0% | 23.3% | 23.32% | 23.82% | 22.21% | 19.92% | 17.2% | 14.67% | 5.14% | 4.03% | 4.37% |
| DIIs | 0% | 2.28% | 2.06% | 7.73% | 8.77% | 9.64% | 10.18% | 9.65% | 16.42% | 16.62% | 15.48% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 4.95% | 5% | 4.06% | 4.36% | 5.41% | 6.99% | 9.36% | 11.56% | 12.25% | 13.05% |
| Others | 21.15% | 17.03% | 17.18% | 11.95% | 12.23% | 12.61% | 13.2% | 13.9% | 14.46% | 14.68% | 14.7% |
| No. of Shareholders | 51 | 80864 | 66400 | 36767 | 33172 | 33159 | 33338 | 36334 | 40333 | 39084 | 39710 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1827.47 | Sell |
| EMA (10) | 1794.39 | Buy |
| SMA (20) | 1683.81 | Buy |
| EMA (20) | 1699.24 | Buy |
| SMA (50) | 1426.21 | Buy |
| EMA (50) | 1505.28 | Buy |
| SMA (100) | 1307.89 | Buy |
| EMA (100) | 1371.68 | Buy |
| SMA (200) | 1206.46 | Buy |
| EMA (200) | 1282.33 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 69.5 | Neutral |
| MACD (12,26,9) | 129.48 | Sell |
| Stochastic (14,3,3) | 76.77 | Neutral |
| ADX (14) | 64.16 | Buy |
| Williams %R (14) | -27.18 | Neutral |
| ATR (14) | 70.29 | High Volatility |
| ROC (12) | 10.16 | Buy |
| Stoch RSI (14) | 8.05 | Buy |
| UO (7,14,28) | 47.02 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 3 analyst ratings, observed at 2026-09-11T04:37:12.549344+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Certificate u/r 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended March 31, 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Certificate u/r 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/104137d6-8e5a-4de0-b0c3-4dd7866d3165.pdf) |
| 6 May - MCA approved fast-track merger of two subsidiaries into Rada Medisolutions, effective 15 April 2025. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 6 May - MCA approved fast-track merger of two subsidiaries into Rada Medisolutions, effective 15 April 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8a4d52aa-7c56-4729-9ce8-6f8ea9eedbad.pdf) |
| 4 Mar - Investor/analyst meetings on 09 Mar 2026 13:00 at Bharat Connect Rising Stars conference; organized by Arihant; virtual. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Mar - Investor/analyst meetings on 09 Mar 2026 13:00 at Bharat Connect Rising Stars conference; organized by Arihant; virtual.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/23d01a50-e0dd-49ca-a4b6-30b9c9002f4f.pdf) |
| 4 Mar - Investor group meeting on 11 March 2026 with Investec India in Mumbai. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Mar - Investor group meeting on 11 March 2026 with Investec India in Mumbai.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8990e17b-2358-4e07-aa63-0b9e31953d73.pdf) |
| 26 Feb - Of Schedule of Analyst/Institutional Investor meet to be held on March 06, 2026 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 26 Feb - Of Schedule of Analyst/Institutional Investor meet to be held on March 06, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/45d98b22-a837-4fc2-ad62-3039a2109106.pdf) |
| 12 Sep - GST Authority levied Rs. 12.92 lakh penalty on ACE Cardiopathy for non-generation of e-invoice, paid under protest. | [Entero Healthcare Solutions Limited Has informed About General Updates 12 Sep - GST Authority levied Rs. 12.92 lakh penalty on ACE Cardiopathy for non-generation of e-invoice, paid under protest.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1792cdf8-c0db-494d-a398-0a92ebca2596.pdf) |
| 11 Mar - Sambit Mohanty resigns as President—Institutional Business; ceases SMP effective close of business March 31, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 11 Mar - Sambit Mohanty resigns as President—Institutional Business; ceases SMP effective close of business March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c25b48ce-5efc-4211-bf3d-b7148ca7347e.pdf) |
| — | [Closure of Trading Window 23 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6e2468e-07ee-4d4b-93a8-0144a0c6a853.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 20 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d1aff0cd-f2a8-4892-b3d4-40f3df5afdb7.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-26 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D33FA89A_F8AE_4E2B_A35B_1AF130535233_171508.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=794cb6eb-8514-49da-97f2-4155e44eabd4.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=730146b7-63fa-4c78-9797-7993c8f48b59.pdf) |
| 2026-08-19 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1808ed98-079e-4d94-9556-4cb8cc10207c.pdf) |
| 2026-08-19 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=466d64b5-e1d4-4cb2-9c46-7a8eec27ee8f.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4403d1f-93d4-42f5-b15c-d5d26b86d15b.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f8b1fab-8a37-42c5-9d0c-886450b07eb5.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 07 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4934ed98-fd4b-4dc7-95d4-d9cea91b27a1.pdf) |
| 2026-08-05 | [Revised Intimation Of The Earnings Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=636ee9fe-423c-47c3-9d41-dd00e2275955.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5d7ef16-7867-4e6b-8184-b2591d51bba0.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=808d85fd-f6c7-4f4a-98d3-f57a32a6e78f.pdf) |
| 2026-06-02 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e299570-e98e-4b7b-bd68-c3ecaaa2ff59.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1aff0cd-f2a8-4892-b3d4-40f3df5afdb7.pdf) |
| 2025-11-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=842e8a5c-9bb1-4e03-b4c6-50eb7d5afbcf.pdf) |
| 2025-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe2f12a3-38ca-41d4-8d68-08c48e3cd53f.pdf) |
| 2025-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=042d196e-564e-4d03-82ae-734195b66e19.pdf) |
| 2025-02-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34d2ef1e-afb0-46b3-be10-f9683b168944.pdf) |
| 2024-11-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b9cf86a-4e0d-4ad1-9188-7a1da0b17f9e.pdf) |
| 2024-08-22 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9d35c12-0e78-4cc5-8ac1-bef5a1266007.pdf) |
| 2024-06-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d4ed965-ae7c-41b9-beca-e7478075f3e7.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80e84d9b-5cab-4e9d-9193-1463efe8a749.pdf) |
| 2026-05-25 | [Results - Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d6adb02-e434-43fd-b046-201034a4bcbe.pdf) |
| 2026-02-12 | [Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79a91338-62b4-405e-9bb8-07c5f0fdb403.pdf) |
| 2025-11-12 | [Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e6d61a4-a72e-4ff3-8bcd-0162a07c6c17.pdf) |
| 2025-08-08 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd4d7d0a-8a34-48ca-b78a-79b6894afef8.pdf) |
| 2025-05-27 | [Results - Audited Financial Results For Quarter And Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3138d551-a011-4dd2-95e8-8f942accf8a2.pdf) |
| 2025-02-12 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bbcee45-bf1f-438f-b543-18230947fe4f.pdf) |
| 2024-11-12 | [Results- Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1968db82-5e8d-4b45-8a99-0a97587e872b.pdf) |
| 2024-08-14 | [Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b03dc339-b4c5-4747-8d09-7f4bb9f76aad.pdf) |
| 2024-05-29 | [Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa7bd06b-3c1b-4e1c-bd44-9074610d5f58.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f86ed28d-3165-49db-8c2b-1e0bf36a82f2.pdf) |
| 2026-05-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dab0db13-9113-4734-9ef1-b6742781c66d.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42b7ec8f-1c9a-4492-bc0d-5dd189b631cc.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78bba0a0-8086-4fae-bbf4-fcc270f57e62.pdf) |
| 2025-08-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e6f1137-7f92-40eb-8992-b849450fbedc.pdf) |
| 2025-05-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9da016fd-37af-4517-9cf3-d43ca3375ceb.pdf) |
| 2025-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05251e70-c020-42d9-b9e1-dfac57f4263e.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffc7a115-3094-4e37-abfc-8b72d3e95810.pdf) |
| 2024-08-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61955ea3-73c2-4356-bed5-dc8bc126e629.pdf) |
| 2024-05-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab9716b5-eb16-4c7b-a6f4-336fd83178fb.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/842e8a5c-9bb1-4e03-b4c6-50eb7d5afbcf.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5b9cf86a-4e0d-4ad1-9188-7a1da0b17f9e.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dab0db13-9113-4734-9ef1-b6742781c66d.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dab0db13-9113-4734-9ef1-b6742781c66d.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/902fc328-a118-4fa4-b24e-ea51eed3892e.pdf) |
| Mar 2024 | [Concall - Mar 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fc264a25-4e8c-4b8d-b9f4-9383cdde4360.pdf) |
| Jun 2026 | [Concall - Jun 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4e299570-e98e-4b7b-bd68-c3ecaaa2ff59.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/042d196e-564e-4d03-82ae-734195b66e19.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d4ed965-ae7c-41b9-beca-e7478075f3e7.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34d2ef1e-afb0-46b3-be10-f9683b168944.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/63ca4e76-520d-4057-bfec-9769100d17ce.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1ee92e80-ec9c-45f5-ae7d-a2809837e81b.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a60229af-cfb8-4872-9fe0-983d08bfa537.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-08-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7554ebde-ea62-43e0-b7ad-1c679d5d3349.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:12:06.564Z.